Holocene Advisors, LP

Position in ELAN — Elanco Animal Health Inc

CIK 1700574 New York, NY

Position in ELAN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$41,706,985

+$34,257,393 QoQ

Shares Held

1,694,717

+414.8% QoQ

Ownership

0.339%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#46

of 518 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Holocene Advisors, LP holds $298,952,947 across 6 Drug Manufacturers - Specialty & Generic names. ELAN ranks #3 (14.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc.	3,601,472	$188,717,132
2	LNTH	Lantheus Holdings, Inc.	546,961	$60,679,853
3	ELAN	Elanco Animal Health Inc This page	1,694,717	$41,706,985
4	TEVA	Teva Pharmaceutical Industries Ltd	166,867	$5,653,453
5	HIMS	Hims & Hers Health, Inc.	38,962	$1,350,812
6	UTHR	UNITED THERAPEUTICS Corp	1,559	$844,712

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$41,706,985	1,694,717	+414.8%	Shares	Sole	2026-08-14
2025-12-31	$7,449,592	329,191	-84.3%	Shares	Sole	2026-02-17
2025-09-30	$42,154,107	2,093,054	-27.5%	Shares	Sole	2025-11-14
2025-06-30	$41,216,278	2,886,294	+29.1%	Shares	Sole	2025-08-14
2025-03-31	$23,482,977	2,236,474	-20.2%	Shares	Sole	2025-05-15
2024-06-30	$40,419,180	2,801,052	-4.3%	Shares	Sole	2024-08-14
2024-03-31	$47,668,393	2,928,034	-20.1%	Shares	Sole	2024-05-15
2023-12-31	$54,595,417	3,664,122	-45.4%	Shares	Sole	2024-02-14
2023-09-30	$75,495,146	6,716,650	+35.1%	Shares	Sole	2023-11-14
2023-06-30	$49,998,159	4,969,996	+63019.1%	Shares	Sole	2023-08-14
2021-06-30	$273,149	7,874	-99.4%	Shares	Sole	2021-08-16
2020-12-31	$37,243,133	1,214,318	-10.4%	Shares	Sole	2021-02-16
2020-06-30	$29,057,092	1,354,643	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.